Company registration number 05332791 (England and Wales)
NEUREGENIX LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024
PAGES FOR FILING WITH REGISTRAR
NEUREGENIX LIMITED
COMPANY INFORMATION
Director
Professor A Logan
Company number
05332791
Registered office
The Oakley
Kidderminster Road
Droitwich
Worcestershire
WR9 9AY
Accountants
Ormerod Rutter Limited
The Oakley
Kidderminster Road
Droitwich
Worcestershire
WR9 9AY
Bankers
HSBC Bank plc
115 High Street
Sittingbourne
Kent
ME10 4AL
NEUREGENIX LIMITED
CONTENTS
Page
Accountants' report
1
Balance sheet
2
Notes to the financial statements
3 - 4
NEUREGENIX LIMITED
ACCOUNTANTS' REPORT TO THE DIRECTOR ON THE PREPARATION OF THE UNAUDITED STATUTORY FINANCIAL STATEMENTS OF NEUREGENIX LIMITED FOR THE YEAR ENDED 31 MARCH 2024
- 1 -

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Neuregenix Limited for the year ended 31 March 2024 which comprise, the balance sheet and the related notes from the company’s accounting records and from information and explanations you have given us.

 

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at https://www.icaew.com/regulation.

This report is made solely to the board of directors of Neuregenix Limited, as a body, in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of Neuregenix Limited and state those matters that we have agreed to state to the board of directors of Neuregenix Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Neuregenix Limited and its board of directors as a body, for our work or for this report.

It is your duty to ensure that Neuregenix Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and loss of Neuregenix Limited. You consider that Neuregenix Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Neuregenix Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

Ormerod Rutter Limited
28 August 2024
Chartered Accountants
The Oakley
Kidderminster Road
Droitwich
Worcestershire
WR9 9AY
NEUREGENIX LIMITED
BALANCE SHEET
AS AT 31 MARCH 2024
31 March 2024
- 2 -
2024
2023
Notes
£
£
£
£
Current assets
Debtors
3
120
52,800
Cash at bank and in hand
2,609
942
2,729
53,742
Creditors: amounts falling due within one year
4
(5,347)
(53,747)
Net current liabilities
(2,618)
(5)
Capital and reserves
Called up share capital
5
140
140
Profit and loss reserves
(2,758)
(145)
Total equity
(2,618)
(5)

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The director acknowledges her responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and signed by the director and authorised for issue on 28 August 2024
Professor A Logan
Director
Company registration number 05332791 (England and Wales)
NEUREGENIX LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024
- 3 -
1
Accounting policies
Company information

Neuregenix Limited is a private company limited by shares incorporated in England and Wales. The registered office is The Oakley, Kidderminster Road, Droitwich, Worcestershire, WR9 9AY.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for services provided in the normal course of business, and is shown net of VAT.

Revenue from contracts for the provision of services is recognised by reference to the stage of completion and where the amount of revenue can be measured reliably.

1.3
Research and development expenditure

Research expenditure is written off against profits in the year in which it is incurred. Identifiable development expenditure is capitalised to the extent that the technical, commercial and financial feasibility can be demonstrated.

Changes in the fair value of derivatives that are designated and qualify as fair value hedges are recognised in profit or loss immediately, together with any changes in the fair value of the hedged asset or liability that are attributable to the hedged risk.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2024
2023
Number
Number
Total
1
1
3
Debtors
2024
2023
Amounts falling due within one year:
£
£
Trade debtors
120
52,800
NEUREGENIX LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2024
- 4 -
4
Creditors: amounts falling due within one year
2024
2023
£
£
Trade creditors
-
0
41,224
Other creditors
5,347
12,523
5,347
53,747
5
Called up share capital
2024
2023
2024
2023
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary of 10p each
1,400
1,400
140
140
6
Ultimate controlling party

There is no ultimate controlling party.

2024-03-312023-04-01false28 August 2024CCH SoftwareCCH Accounts Production 2024.100No description of principal activityProfessor A Loganfalsefalse053327912023-04-012024-03-3105332791bus:Director12023-04-012024-03-3105332791bus:RegisteredOffice2023-04-012024-03-3105332791bus:Agent12023-04-012024-03-31053327912024-03-31053327912023-03-3105332791core:CurrentFinancialInstrumentscore:WithinOneYear2024-03-3105332791core:CurrentFinancialInstrumentscore:WithinOneYear2023-03-3105332791core:CurrentFinancialInstruments2024-03-3105332791core:CurrentFinancialInstruments2023-03-3105332791core:ShareCapital2024-03-3105332791core:ShareCapital2023-03-3105332791core:RetainedEarningsAccumulatedLosses2024-03-3105332791core:RetainedEarningsAccumulatedLosses2023-03-31053327912022-04-012023-03-3105332791bus:PrivateLimitedCompanyLtd2023-04-012024-03-3105332791bus:SmallCompaniesRegimeForAccounts2023-04-012024-03-3105332791bus:FRS1022023-04-012024-03-3105332791bus:AuditExemptWithAccountantsReport2023-04-012024-03-3105332791bus:FullAccounts2023-04-012024-03-31xbrli:purexbrli:sharesiso4217:GBP